Withings Redefines Preventive Health with Body Scan 2
After inventing the world’s first connected scale in 2009, Withings is redefining preventive health once again with Body Scan 2, the most advanced home longevity station...
Category : Biomarkers
Circular Genomics Adds Leading Alzheimer’s Experts to SAB
Michael Weiner, MD and Timothy Hohman, PhD, bring decades of experience in neurological diseases with a focus on Alzheimer’s disease Circular Genomics, a leader in...
Circular Genomics Announces Closure of $15 Million Series A Financing
Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-class performance Circular Genomics, Inc.,...
Quanterix Announces Board and Leadership Changes for Next Growth Phase
Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director...
AI Detects First Imaging Biomarker of Chronic Stress
Using a deep learning AI model, researchers identified the first-of-its-kind biomarker of chronic stress detectable through routine imaging, according to research being presented next week...
Adalyon Appoints Ulrik Zeuthen as CEO
Adalyon, a pioneering tech-bio company using its AI-powered speech biomarker platform to transform clinical drug development, today announced the appointment of Ulrik Zeuthen, as Chief...
Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer
Freenome building commercial infrastructure following recent CLIA lab certification and early access program for key health system partners, with new test launches for colorectal cancer,...
Canary Speech on TIME’s List of the World’s Top HealthTech Companies 2025
Canary Speech, the leading AI-powered voice biomarker health tech company, has been included in the first edition of the World’s Top HealthTech Companies 2025. This...
Artera Presents AI Platform for Faster, Personalized Cancer Treatment
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present four abstracts at the 2025 American Society for Radiation Oncology...
Caristo Applauds Abcentra for Successful Phase 2b Trial Start
‘FORTIFY’ Selects FAI-Score™ as Primary Outcome Measure, and Caristo as Worldwide Imaging Core Lab for Coronary Inflammation and Plaque Measurement and Monitoring Caristo Diagnostics, on a mission...